SAN DIEGO, March 27, 2019 /PRNewswire/ — Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of WellCare Health Plans, Inc. (NYSE: WCG) (“WellCare”) breached their fiduciary duties in connection with the proposed sale of the Company to Centene Corporation (NYSE: CNC) (“Centene”).
On March 27, 2019, WellCare announced that it had signed a definitive merger agreement with Centene. Under the terms of the merger agreement, WellCare shareholders will receive a fixed exchange ratio of 3.38 shares of Centene common stock and $120 in cash for each share of WellCare common stock. Based on Centene’s closing stock price on March 26, 2019, the implied cash and stock consideration to be received by WellCare shareholders is $305.39 per share. However, shareholders will be subject to the future price fluctuation of Centene’s stock price.
The investigation concerns whether the WellCare board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for WellCare shares of common stock. Nationally recognized Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given analysts’ projections for future earnings and revenue growth, also one Wall Street analyst has a $360.00 price target on the stock. The 52-week high for WellCare was $324.99.
If you are a shareholder of WellCare and believe the proposed buyout price is too low or you’re interested in learning more about the investigation or your legal rights and remedies, please contact lead analyst Jim Baker (firstname.lastname@example.org) at 619-814-4471. If emailing, please include a phone number.
Additionally, you can [Click here to join this action]. There is no cost or obligation to you.
About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit https://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.
Johnson Fistel, LLP
Jim Baker, 619-814-4471
[Click here to join this action]
SOURCE Johnson Fistel, LLP